A class action lawsuit alleges a 'cartel' led by Good Day Farm is manipulating the Missouri cannabis market, exceeding license caps and suppressing ...

The proposed US Lawful Hemp Protection Act seeks to redefine industrial hemp policy by curbing synthetic intoxicants and ...

Safe Harbor has expanded its medical cannabis financing platform, offering new lending capabilities for commercial real ...

A U.S. Senate committee is reviewing a bill to boost veterans' psychedelic therapy research within the VA. S. 4220 aims to ...

Explore how Multi-State Operator TerrAscend is reportedly leading the cannabis industry forward, according to MJBizDaily.

Explore the latest developments in federal cannabis rescheduling, including the DEA's new registration process for medical ...

A U.S. congressional committee expresses concerns over unsubstantiated health claims for medical cannabis products, urging ...

Trump's partial medical cannabis rescheduling from Schedule I to III causes industry confusion. Learn its impact on medical ...

The global medical cannabis market is set to reach US$148.9 billion by 2031, fueled by regulatory reforms and expanding ...

The Trump administration is re-evaluating its stance on federal law 922(g)(3), which impacts medical cannabis gun rights.

The US Justice Department's Schedule III reclassification for medical cannabis products is revitalizing investor interest.

The US House has passed the 2026 Farm Bill, retaining a ban on intoxicating hemp products. This decision creates significant ...